针对JNK守门员:MK4和MK7抑制剂的结构演变和药物化学
Min Zhao1, Baojian Li1,2, Ying Gao1,2
1School of Pharmacy, Xinjiang Second Medical College, Karamay 834000, China.
Molecules (Basel, Switzerland)
|February 27, 2026
概括
准MK4和MK7激酶可以精确控制c-Jun N-终端激酶 (JNK) 途径. MKK4 抑制剂对肝脏再生有很大的前景,而 MKK7 抑制剂针对纤维化和炎症.
科学领域:
- 生物化学 生物化学
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- c-Jun N-终端激酶 (JNK) 途径与纤维化,炎症和神经退行有关.
- 直接的JNK抑制剂面临的异型选择性挑战.
- 上游准MKK4和MK7激酶提供了更精确的治疗策略.
研究的目的:
- 审查针对MKK4和MK7.7的小分子抑制剂的结构生物学和药物开发.
- 为了对比MKK4和MKK7抑制的治疗应用.
- 探索MKK-JNK轴的先进治疗方式.
主要方法:
- 关于结构生物学和药物化学的文献综述.
- 对向MKK4和MK7.7的小分子抑制剂的分析.
- 基于结构的设计策略和新兴模式的评估.
主要成果:
- 抑制MKK4是肝脏再生的一个有希望的策略,HRX215作为临床例子.
- 对于抗纤维和抗炎作用,MKK7抑制是追求的.
- 基于结构的设计,包括对MKK7的Cys218的共价准,提高了选择性.
结论:
- 针对MKK4和MK7提供了一个精确的方法来调节JNK通路.
- 在MKK4和MK7抑制方面存在明显的治疗潜力.
- 新一代疗法,包括PROTACs和双抑制剂,正在为MKK-JNK轴出现.
相关概念视频
MAPK Signaling Cascades
8.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.8K
The JAK-STAT Signaling Pathway
13.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.4K
Interactions Between Signaling Pathways
7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
PI3K/mTOR/AKT Signaling Pathway
5.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.9K
Amplifying Signals via Enzymatic Cascade
18.7K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.7K


